| tyyppi : |
Lehti |
| Internet-yhteys : |
http://dx.doi.org/ 10.1136/ejhpharm-2020- 002340 |
|
| tutkimus Joukkueet : |
Birmingham - Queen Elisabeth Hospital, Pharmacy Department |
| Tekijät : |
Jamieson C,Ozolina L,Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS. |
| Otsikko : |
Assessment of the stability of citrate- buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements |
| Numero : |
EJHP 2020;0:1-5. 2020 |
|
| Todisteiden määrä : |
|
| fyysinen vakaus : |
|
| kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| commentairesvaleur : |
|
Luettelo yhdisteistä
 Piperacillin sodium / tazobactam
|
 |
 |
 |
 |
22 / 3 mg/ml |
2-8°C |
 |
| 13 |
 |
|
|
|
|
|
22 / 3 mg/ml |
32°C |
|
| 24 |
 |
|
|
|
|
|
80 / 10 mg/ml |
2-8°C |
|
| 13 |
|
|
|
|
|
|
80 / 10 mg/ml |
32°C |
|
| 24 |
|
|
|
|
 |
|
22 / 3 mg/ml |
2-8°C |
|
| 13 |
|
|
|
|
|
|
22 / 3 mg/ml |
32°C |
|
| 24 |
|
|
|
|
|
|
80 / 10 mg/ml |
2-8°C |
|
| 13 |
|
|
|
|
|
|
80 / 10 mg/ml |
32°C |
|
| 24 |
|
|
|
|
|
